Examination of Low ERBB2 Protein Expression in Breast Cancer TissueAileen I. Fernandez, David L. Rimm, Serena Wong et al.|JAMA Oncology|2022Cited by 347
Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancerSaman Farahmand, Kourosh Zarringhalam, Aileen I. Fernandez et al.|Modern Pathology|2021Cited by 166
Multi-institutional Assessment of Pathologist Scoring HER2 ImmunohistochemistryCharles T. Robbins, David L. Rimm, Aileen I. Fernandez et al.|Modern Pathology|2023Cited by 98
Association between low estrogen receptor positive breast cancer and staining performanceDennis L. Caruana, Emily Reisenbichler|npj Breast Cancer|2020Cited by 27
Multi-institutional Assessment of Pathologist scoring HER2 ImmunohistochemistryCharles T. Robbins, David L. Rimm, Aileen I. Fernandez et al.|Research Square|2022Cited by 7